🇺🇸 MSC-1 in United States
5 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 5
Most-reported reactions
- Covid-19 — 1 report (20%)
- Febrile Neutropenia — 1 report (20%)
- Haemophilus Infection — 1 report (20%)
- Lung Infiltration — 1 report (20%)
- Thrombocytopenia — 1 report (20%)
Frequently asked questions
Is MSC-1 approved in United States?
MSC-1 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for MSC-1 in United States?
AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.